NRF2 induces the expression of various antioxidant genes, such as HO-1, GCLC, GCLM, GST, and CAT, to mitigate oxidative damage, initially exerting tumor-suppressive effects [154,155]. This evidence concerns the gene HMOX1 and neoplasm.